Evidence map›Paper›PMID 35983857›Full record

ArticleMedical physics2023

Experimental validation of Monte Carlo dosimetry for therapeutic beta emitters with radiochromic film in a 3D-printed phantom.

Benjamin Van, Yuni K Dewaraja, Jeremy T Niedbala, Gerrid Rosebush, Matthew Kazmierski, David Hubers, Justin K Mikell, Scott J Wilderman

Open access · greenAbstract read
In one paragraph

Article in Medical physics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. A review on radiochromic film dosimetry in radiation therapy.Journal of applied clinical medical physics · 2025
    Review
  3. Monte Carlo methods for medical imaging research.Biomedical engineering letters · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Benjamin VanDepartment of Radiology, Michigan Medicine, Ann Arbor, Michigan, USA.
Yuni K DewarajaDepartment of Radiology, Michigan Medicine, Ann Arbor, Michigan, USA.
Jeremy T NiedbalaDepartment of Radiology, Michigan Medicine, Ann Arbor, Michigan, USA.
Gerrid RosebushDepartment of Radiology, Michigan Medicine, Ann Arbor, Michigan, USA.
Matthew KazmierskiDepartment of Radiology, Michigan Medicine, Ann Arbor, Michigan, USA.
David HubersDepartment of Radiology, Michigan Medicine, Ann Arbor, Michigan, USA.
Justin K MikellDepartment of Radiation Oncology, Michigan Medicine, Ann Arbor, Michigan, USA.
Scott J WildermanDepartment of Nuclear Engineering and Radiologic Sciences, University of Michigan, Ann Arbor, Michigan, USA.
Michigan Medicine · USWashington University in St. Louis · US

Funding

Imaging and Dosimetry of Yttrium-90 for Personalized Cancer TreatmentR01EB022075 · NIBIB · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DEWARAJA, YUNI K · 2016 to 2023
$4.7M
Bringing Capacity for Theranostic Dosimetry Planning to the Nuclear Medicine ClinicR01CA240706 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI DEWARAJA, YUNI K · 2020 to 2024
$3.0M
National Cancer Institute; NIH R01CA240706NCI NIH HHS R01 CA240706NIBIB NIH HHS R01 EB022075
6 · The paper itself

Abstract

purposeValidation of dosimetry software, such as Monte Carlo (MC) radiation transport codes used for patient-specific absorbed dose estimation, is critical prior to their use in clinical decision making. However, direct experimental validation in the clinic is generally not performed for low/medium-energy beta emitters used in radiopharmaceutical therapy (RPT) due to the challenges of measuring energy deposited by short-range particles. Our objective was to design a practical phantom geometry for radiochromic film (RF)-based absorbed dose measurements of beta-emitting radionuclides and perform experiments to directly validate our in-house developed Dose Planning Method (DPM) MC code dedicated to internal dosimetry.

methodsThe experimental setup was designed for measuring absorbed dose from beta emitters that have a range sufficiently penetrating to ∼200 μm in water as well as to capture any photon contributions to absorbed dose. Assayed

resultsA total of 20 experiments showed that both the 3D-printed phantoms and the final absorbed dose values were reproducible. The agreement between the absorbed dose estimates from the RF measurements and DPM was on average -4.0% (range -10.9% to 3.2%) for all single film

conclusionsThe reproducible results with a RF insert in a simple phantom designed for liquid sources demonstrate that this is a reliable setup for experimentally validating dosimetry algorithms used in therapies with beta-emitting unsealed sources. Absorbed doses estimated with the DPM MC code showed close agreement with RF measurement and with results from two general purpose MC codes, thereby validating the use of this algorithms for clinical RPT dosimetry.

Indexed as

RadiometrySoftwareAlgorithmsFilm DosimetryHumansMonte Carlo MethodPhantoms, ImagingPrinting, Three-DimensionalRadiotherapy Dosagedosimetrymonte carloradiopharmaceutical therapy

Identifiers

PMID35983857
PMCPMC10019496
OpenAlexW4292318612

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.